Literature DB >> 2548304

Possible mechanism of chrysotile asbestos-stimulated superoxide anion production in guinea pig alveolar macrophages.

P L Roney1, A Holian.   

Abstract

Excessive production of active oxygen radicals by macrophages is proposed to play an important role in asbestos-related diseases. The purpose of this study was to examine the capacity and mechanisms of action of various forms of asbestos to stimulate superoxide anion production by guinea pig alveolar macrophages. Chrysotile, but not the amphiboles (crocidolite, anthophyllite, or amosite), stimulated a rapid (less than 1 min) and dose-dependent (2.5-50 micrograms/ml) production of superoxide anion at noncytotoxic doses (2.5 to 25 micrograms/ml). The stimulation of superoxide anion production by chrysotile could be blocked by putative protein kinase C inhibitors (staurosporine, sphingosine, and fluphenazine). Chrysotile also stimulated phosphatidylinositol turnover as measured using 32Pi incorporation into phospholipids, [3H]-diacylglycerol levels, and intracellular calcium mobilization as measured using fura-2 and 45Ca. In addition, pertussis toxin partially blocked chrysotile-stimulated superoxide anion production. We conclude that the mechanism of guinea pig alveolar macrophage stimulation by chrysotile, but not the amphibole asbestos forms, is consistent with a mechanism which is similar to that used by agonists such as N-formyl-Nle-Leu-Phe resulting in stimulated phosphatidylinositol turnover, calcium mobilization, and activation of protein kinase C.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2548304     DOI: 10.1016/0041-008x(89)90097-5

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  12 in total

Review 1.  The molecular basis of asbestos induced lung injury.

Authors:  D W Kamp; S A Weitzman
Journal:  Thorax       Date:  1999-07       Impact factor: 9.139

2.  Differences in the effects of two hexa-chlorophenols on superoxide generation by polymorphonuclear leucocytes stimulated by N-formyl-methionyl-leucyl-phenylalanine and phorbol myristate acetate.

Authors:  P L Roney
Journal:  Occup Environ Med       Date:  1995-01       Impact factor: 4.402

3.  Pirfenidone inhibits NADPH-dependent microsomal lipid peroxidation and scavenges hydroxyl radicals.

Authors:  H P Misra; C Rabideau
Journal:  Mol Cell Biochem       Date:  2000-01       Impact factor: 3.396

Review 4.  Selected new developments in asbestos immunotoxicity.

Authors:  G J Rosenthal; E Corsini; P Simeonova
Journal:  Environ Health Perspect       Date:  1998-02       Impact factor: 9.031

5.  Differential release of superoxide anions by macrophages treated with long and short fibre amosite asbestos is a consequence of differential affinity for opsonin.

Authors:  I M Hill; P H Beswick; K Donaldson
Journal:  Occup Environ Med       Date:  1995-02       Impact factor: 4.402

6.  Induction of macrophage plasminogen activator by asbestos is independent of PKC activation.

Authors:  D Lison; F Raguzzi; R Lauwerys
Journal:  Arch Toxicol       Date:  1991       Impact factor: 5.153

7.  Mechanistic aspects of cromolyn sodium action on the alveolar macrophage: inhibition of stimulation by soluble agonists.

Authors:  A Holian; R Hamilton; R K Scheule
Journal:  Agents Actions       Date:  1991-07

8.  AKT/mTOR and c-Jun N-terminal kinase signaling pathways are required for chrysotile asbestos-induced autophagy.

Authors:  Ziying Lin; Tie Liu; David W Kamp; Yahong Wang; Huijuan He; Xu Zhou; Donghong Li; Lawei Yang; Bin Zhao; Gang Liu
Journal:  Free Radic Biol Med       Date:  2014-04-13       Impact factor: 7.376

9.  Involvement of protein kinase C, phospholipase C, and protein tyrosine kinase pathways in oxygen radical generation by asbestos-stimulated alveolar macrophage.

Authors:  Y Lim; S H Kim; K A Kim; M W Oh; K H Lee
Journal:  Environ Health Perspect       Date:  1997-09       Impact factor: 9.031

Review 10.  Asbestos-induced lung disease.

Authors:  A R Brody
Journal:  Environ Health Perspect       Date:  1993-04       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.